In the dynamic landscape of the health care sector, CLARIANE SE, formerly known as Korian SE, continues to make significant strides as a leading provider of dependency care services across Europe. With a robust presence in France, Germany, Italy, and Belgium, the company has established itself as a cornerstone in the health care industry, particularly in the realm of specialized care facilities.
As of the latest financial data, CLARIANE SE’s close price on August 25, 2026, stood at 3.998 EUR, reflecting a market capitalization of approximately 1.43 billion EUR. This valuation underscores the company’s substantial footprint in the health care sector, despite a challenging market environment. The 52-week high of 4.906 EUR, recorded on October 1, 2025, juxtaposed with a low of 3.27 EUR on November 17, 2025, illustrates the volatility and resilience of the company’s stock performance over the past year.
Founded in 2001 and based in Paris, France, CLARIANE SE has grown exponentially since its initial public offering on November 24, 2006. The company’s strategic focus on dependency care services has enabled it to operate approximately 780 facilities, encompassing nursing homes, specialized clinics, assisted living facilities, and comprehensive hospital care and home-care service networks. These facilities collectively offer around 76,000 beds, catering to a diverse range of patient needs and preferences.
The company’s commitment to excellence in care is evident in its extensive network and the breadth of services provided. By specializing in dependency care, CLARIANE SE addresses a critical and growing demand within the health care sector, particularly as populations age and the need for specialized care increases. This focus not only positions the company as a leader in its field but also as a vital contributor to the health care systems of the countries in which it operates.
Despite a high price-to-earnings ratio of 104.85235, indicative of investor expectations for future growth, CLARIANE SE continues to navigate the complexities of the health care market with strategic acumen. The company’s ability to maintain a strong market presence, even in fluctuating economic conditions, speaks to its operational efficiency and the enduring value of its services.
For stakeholders and potential investors, CLARIANE SE represents a compelling opportunity within the health care sector. Its extensive network, specialized focus, and strategic positioning in key European markets underscore its potential for sustained growth and impact. As the company continues to evolve and expand its services, it remains a pivotal player in addressing the nuanced needs of dependency care across Europe.
For more detailed information about CLARIANE SE, interested parties are encouraged to visit the company’s website at www.korian.com or explore trading opportunities on the NYSE Euronext Paris, where the company is publicly listed. As CLARIANE SE moves forward, its commitment to enhancing the quality of life for those in need of specialized care remains at the forefront of its mission, driving innovation and excellence in the health care sector.
